Trials / Recruiting
RecruitingNCT06179017
Endovascular Treatment for Mild Stroke With Acute Anterior Circulation Large Vessel Occlusion
Endovascular Treatment for Mild Stroke With Acute Anterior Circulation Large Vessel Occlusion:a Multicenter Randomized Controlled Trail
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- Sponsor
- Zhangzhou Municipal Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Exploring the Efficacy and Safety of Emergent Endovascular Treatment in Patients with Mild Ischemic Stroke Caused by Acute Anterior Circulation Large Vessel Occlusion based on Perfusion Imaging Screening
Detailed description
This study aims to select suitable patients with mild AIS caused by anterior circulation LVO with mismatch volume of the ischemic penumbra based on screen of cerebral perfusion imaging. It is a prospective, multicenter, endpoint-blinded, randomized controlled trial design, and aim to explore the efficacy and safety of EVT for mild AIS patients with anterior circulation large vessel occlusion within 24 hours of onset.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Experimental group:Intervention Group | Intervention Group:Interventionist choose the optimal endovascular treatment (EVT) strategy and device based on the patient's condition and local guidelines. The patient will receive the best medical treatment according to the local guidelines. |
| OTHER | Control group:best medical treatment | Best medical treatment:Patients will receive the best medical treatment according to local guidelines, including antiplatelet agents, anticoagulants, thrombolysis, etc., but not any EVT. In the control arm, rescue EVT is allowed in patients with disease progression leading to an increase in NIHSS≥4 and excluding the impact of non-stroke factors, and the onset-to-treatment time is within 24 hours. |
Timeline
- Start date
- 2024-02-07
- Primary completion
- 2026-05-30
- Completion
- 2026-05-30
- First posted
- 2023-12-21
- Last updated
- 2026-03-17
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06179017. Inclusion in this directory is not an endorsement.